| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.589 | 0.009 | 0.589 | GABA C receptor rho-3 antagonist | 0.58 0.01 CID_169730 | ||
| 0.549 | 0.004 | 0.7 | Alpha-N-acetylglucosaminidase inhibitor | 0.7 0.003 CID_169730 | CID_169730 | |
| 0.534 | 0.028 | 0.667 | Aldehyde oxidase inhibitor | 0.667 0.011 CID_169730 | CID_169730 | |
| 0.515 | 0.025 | 0.566 | 5 Hydroxytryptamine release stimulant | 0.566 0.018 CID_169730 | CID_169730 | |
| 0.506 | 0.031 | 0.507 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.507 0.031 CID_169730 | CID_169730 | |
| 0.436 | 0.004 | 0.576 | GABA C receptor agonist | 0.576 0.003 CID_169730 | CID_169730 | |
| 0.445 | 0.015 | 0.543 | Peroxidase inhibitor | 0.543 0.006 CID_169730 | CID_169730 | |
| 0.459 | 0.048 | 0.527 | 5 Hydroxytryptamine release inhibitor | 0.527 0.025 CID_169730 | CID_169730 | |
| 0.41 | 0.013 | 0.43 | 5 Hydroxytryptamine uptake stimulant | 0.43 0.009 CID_169730 | CID_169730 | |
| 0.381 | 0.01 | 0.437 | Tyrosine 3 hydroxylase inhibitor | 0.437 0.005 CID_169730 | CID_169730 | |
| 0.355 | 0.005 | 0.428 | Ferrochelatase inhibitor | 0.428 0.003 CID_169730 | CID_169730 | |
| 0.319 | 0.011 | 0.319 | Anesthetic local | |||
| 0.411 | 0.104 | 0.463 | Caspase 9 stimulant | 0.463 0.076 CID_169730 | CID_169730 | |
| 0.351 | 0.049 | 0.368 | Calcium channel activator | 0.368 0.039 CID_169730 | CID_169730 | |
| 0.339 | 0.039 | 0.435 | Superoxide dismutase inhibitor | 0.435 0.021 CID_169730 | CID_169730 | |
| 0.301 | 0.01 | 0.383 | Succinate dehydrogenase inhibitor | 0.383 0.004 CID_169730 | CID_169730 | |
| 0.285 | 0.011 | 0.366 | UDP-glucose 4-epimerase inhibitor | 0.366 0.007 CID_169730 | CID_169730 | |
| 0.281 | 0.017 | 0.3 | Nitric-oxide synthase stimulant | 0.3 0.011 CID_169730 | CID_169730 | |
| 0.263 | 0.011 | 0.263 | 5 Hydroxytryptamine 3E antagonist | 0.238 0.022 CID_169730 | ||
| 0.257 | 0.006 | 0.364 | Triose-phosphate isomerase inhibitor | 0.364 0.004 CID_169730 | CID_169730 | |
| 0.247 | 0.01 | 0.333 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.333 0.005 CID_169730 | CID_169730 | |
| 0.341 | 0.104 | 0.439 | Histamine release inhibitor | 0.439 0.055 CID_169730 | CID_169730 | |
| 0.241 | 0.007 | 0.296 | GABA C receptor antagonist | 0.296 0.004 CID_169730 | CID_169730 | |
| 0.243 | 0.013 | 0.258 | GABA C receptor rho-2 antagonist | 0.258 0.01 CID_169730 | CID_169730 | |
| 0.268 | 0.04 | 0.336 | RNA-directed DNA polymerase inhibitor | 0.336 0.026 CID_169730 | CID_169730 | |
| 0.227 | 0.009 | 0.321 | NADH dehydrogenase inhibitor | 0.321 0.006 CID_169730 | CID_169730 | |
| 0.305 | 0.088 | 0.401 | Cholesterol antagonist | 0.401 0.049 CID_169730 | CID_169730 | |
| 0.223 | 0.012 | 0.293 | Adenylate kinase inhibitor | 0.293 0.007 CID_169730 | CID_169730 | |
| 0.215 | 0.01 | 0.334 | Porphobilinogen synthase inhibitor | 0.334 0.005 CID_169730 | CID_169730 | |
| 0.21 | 0.006 | 0.501 | Alcohol oxidase inhibitor | 0.501 0.004 CID_169730 | CID_169730 | |
| 0.258 | 0.062 | 0.323 | DNA synthesis inhibitor | 0.323 0.037 CID_169730 | CID_169730 | |
| 0.212 | 0.023 | 0.227 | Arachidonic acid antagonist | 0.227 0.013 CID_169730 | CID_169730 | |
| 0.211 | 0.022 | 0.278 | Cystathionine beta-synthase inhibitor | 0.278 0.012 CID_169730 | CID_169730 | |
| 0.199 | 0.011 | 0.263 | Creatine kinase inhibitor | 0.263 0.005 CID_169730 | CID_169730 | |
| 0.193 | 0.009 | 0.229 | GABA C receptor rho-1 antagonist | 0.229 0.005 CID_169730 | CID_169730 | |
| 0.19 | 0.008 | 0.269 | Carbamoyl phosphate synthetase inhibitor | 0.269 0.005 CID_169730 | CID_169730 | |
| 0.231 | 0.051 | 0.283 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.283 0.029 CID_169730 | CID_169730 | |
| 0.185 | 0.005 | 0.196 | Ca2+-transporting ATPase inhibitor | 0.196 0.004 CID_169730 | CID_169730 | |
| 0.193 | 0.017 | 0.193 | 5 Hydroxytryptamine 3A agonist | 0.172 0.025 CID_169730 | ||
| 0.202 | 0.029 | 0.232 | Mannose-6-phosphate isomerase inhibitor | 0.232 0.017 CID_169730 | CID_169730 | |
| 0.231 | 0.059 | 0.301 | Anesthetic general | 0.301 0.033 CID_169730 | CID_169730 | |
| 0.258 | 0.089 | 0.297 | Insulysin inhibitor | 0.297 0.06 CID_169730 | CID_169730 | |
| 0.181 | 0.013 | 0.24 | Phosphofructokinase-1 inhibitor | 0.24 0.008 CID_169730 | CID_169730 | |
| 0.246 | 0.082 | 0.294 | Interleukin agonist | 0.294 0.051 CID_169730 | CID_169730 | |
| 0.246 | 0.084 | 0.278 | Gastrin inhibitor | 0.278 0.05 CID_169730 | CID_169730 | |
| 0.242 | 0.083 | 0.242 | 5 Hydroxytryptamine 1E antagonist | 0.221 0.107 CID_169730 | ||
| 0.179 | 0.026 | 0.199 | Adenylate cyclase stimulant | 0.199 0.014 CID_169730 | CID_169730 | |
| 0.159 | 0.008 | 0.199 | Acyl-CoA dehydrogenase inhibitor | 0.199 0.005 CID_169730 | CID_169730 | |
| 0.16 | 0.008 | 0.227 | Biliverdin reductase inhibitor | 0.227 0.005 CID_169730 | CID_169730 | |
| 0.165 | 0.014 | 0.205 | Electrolyte absorption antagonist | 0.205 0.008 CID_169730 | CID_169730 | |
| 0.212 | 0.065 | 0.246 | Neurotrophic factor enhancer | 0.246 0.041 CID_169730 | CID_169730 | |
| 0.16 | 0.017 | 0.192 | DOPA decarboxylase inhibitor | 0.192 0.008 CID_169730 | CID_169730 | |
| 0.156 | 0.015 | 0.229 | Glutamate dehydrogenase inhibitor | 0.229 0.008 CID_169730 | CID_169730 | |
| 0.194 | 0.055 | 0.194 | 3C-like protease (Human coronavirus) inhibitor | 0.191 0.057 CID_169730 | ||
| 0.163 | 0.032 | 0.2 | Aminopeptidase B inhibitor | 0.2 0.021 CID_169730 | CID_169730 | |
| 0.173 | 0.043 | 0.187 | CF transmembrane conductance regulator agonist | 0.187 0.03 CID_169730 | CID_169730 | |
| 0.14 | 0.015 | 0.201 | Glutamate decarboxylase inhibitor | 0.201 0.007 CID_169730 | CID_169730 | |
| 0.143 | 0.021 | 0.242 | Histidine decarboxylase inhibitor | 0.242 0.009 CID_169730 | CID_169730 | |
| 0.133 | 0.015 | 0.148 | Glutamate release inhibitor | 0.148 0.01 CID_169730 | CID_169730 | |
| 0.127 | 0.01 | 0.177 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.177 0.007 CID_169730 | CID_169730 | |
| 0.143 | 0.028 | 0.197 | HIV-1 integrase (Overall Integration) inhibitor | 0.197 0.012 CID_169730 | CID_169730 | |
| 0.171 | 0.057 | 0.211 | Interferon gamma antagonist | 0.211 0.037 CID_169730 | CID_169730 | |
| 0.138 | 0.025 | 0.15 | Anabolic | 0.15 0.018 CID_169730 | CID_169730 | |
| 0.127 | 0.014 | 0.188 | Argininosuccinate synthase inhibitor | 0.188 0.008 CID_169730 | CID_169730 | |
| 0.155 | 0.043 | 0.162 | Cathepsin H inhibitor | 0.162 0.038 CID_169730 | CID_169730 | |
| 0.118 | 0.006 | 0.182 | Aconitate hydratase inhibitor | 0.182 0.004 CID_169730 | CID_169730 | |
| 0.176 | 0.066 | 0.216 | Phospholipase C inhibitor | 0.216 0.035 CID_169730 | CID_169730 | |
| 0.126 | 0.016 | 0.206 | Phenylalanine 4-hydroxylase inhibitor | 0.206 0.006 CID_169730 | CID_169730 | |
| 0.138 | 0.028 | 0.158 | Prolactin inhibitor | 0.158 0.019 CID_169730 | CID_169730 | |
| 0.122 | 0.015 | 0.129 | Granulocyte macrophage colony stimulating factor agonist | 0.129 0.011 CID_169730 | CID_169730 | |
| 0.157 | 0.051 | 0.18 | Sphingosine 1-phosphate receptor 5 antagonist | 0.18 0.024 CID_169730 | CID_169730 | |
| 0.122 | 0.019 | 0.155 | Aminopeptidase I inhibitor | 0.155 0.012 CID_169730 | CID_169730 | |
| 0.127 | 0.024 | 0.143 | Lanosterol 14 alpha demethylase inhibitor | 0.143 0.014 CID_169730 | CID_169730 | |
| 0.119 | 0.019 | 0.132 | Glycine receptor antagonist | 0.132 0.013 CID_169730 | CID_169730 | |
| 0.146 | 0.046 | 0.164 | Sphingosine 1-phosphate receptor 2 antagonist | 0.164 0.026 CID_169730 | CID_169730 | |
| 0.13 | 0.031 | 0.195 | Catalase inhibitor | 0.195 0.016 CID_169730 | CID_169730 | |
| 0.104 | 0.007 | 0.104 | Exportin-1 inhibitor | 0.098 0.01 CID_169730 | ||
| 0.156 | 0.061 | 0.235 | Amylase inhibitor | 0.235 0.032 CID_169730 | CID_169730 | |
| 0.1 | 0.005 | 0.128 | Glucose-6-phosphate isomerase inhibitor | 0.128 0.003 CID_169730 | CID_169730 | |
| 0.165 | 0.07 | 0.187 | Neurotensin receptor agonist | 0.187 0.043 CID_169730 | CID_169730 | |
| 0.133 | 0.038 | 0.175 | Carbonic anhydrase XV inhibitor | 0.175 0.023 CID_169730 | CID_169730 | |
| 0.103 | 0.009 | 0.13 | Glutamate (mGluR6) antagonist | 0.13 0.005 CID_169730 | CID_169730 | |
| 0.147 | 0.053 | 0.159 | Heat shock protein 70 antagonist | 0.159 0.029 CID_169730 | CID_169730 | |
| 0.109 | 0.016 | 0.139 | Glycine receptor agonist | 0.139 0.008 CID_169730 | CID_169730 | |
| 0.145 | 0.053 | 0.163 | Cyclooxygenase 3 inhibitor | 0.163 0.038 CID_169730 | CID_169730 | |
| 0.104 | 0.014 | 0.107 | Vanilloid 4 agonist | 0.107 0.012 CID_169730 | CID_169730 | |
| 0.237 | 0.147 | 0.279 | Vasodilator, coronary | 0.279 0.106 CID_169730 | CID_169730 | |
| 0.109 | 0.02 | 0.126 | D-Ala-D-Ala ligase inhibitor | 0.126 0.011 CID_169730 | CID_169730 | |
| 0.101 | 0.013 | 0.101 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.101 0.013 CID_169730 | ||
| 0.103 | 0.015 | 0.134 | Purinergic P2X1 antagonist | 0.134 0.009 CID_169730 | CID_169730 | |
| 0.147 | 0.059 | 0.154 | Pregnane X receptor agonist | 0.154 0.046 CID_169730 | CID_169730 | |
| 0.117 | 0.032 | 0.119 | Histamine N-methyltransferase inhibitor | 0.119 0.03 CID_169730 | CID_169730 | |
| 0.164 | 0.079 | 0.189 | ATPase inhibitor | 0.189 0.047 CID_169730 | CID_169730 | |
| 0.118 | 0.033 | 0.12 | Glutamate (mGluR7) agonist | 0.12 0.03 CID_169730 | CID_169730 | |
| 0.104 | 0.02 | 0.118 | Estrogen-related receptor beta agonist | 0.118 0.011 CID_169730 | CID_169730 | |
| 0.125 | 0.041 | 0.125 | Acetylcholine release stimulant | 0.121 0.047 CID_169730 | ||
| 0.096 | 0.013 | 0.105 | Glutamate (mGluR7) antagonist | 0.105 0.008 CID_169730 | CID_169730 | |
| 0.129 | 0.047 | 0.151 | Photosensitizer | 0.151 0.03 CID_169730 | CID_169730 | |
| 0.112 | 0.03 | 0.112 | CYP2A6 inhibitor | 0.095 0.038 CID_169730 | ||
| 0.137 | 0.056 | 0.193 | Aldehyde dehydrogenase inhibitor | 0.193 0.029 CID_169730 | CID_169730 | |
| 0.097 | 0.017 | 0.105 | Phospholipase D inhibitor | 0.105 0.012 CID_169730 | CID_169730 | |
| 0.094 | 0.021 | 0.118 | GABA B receptor agonist | 0.118 0.008 CID_169730 | CID_169730 | |
| 0.128 | 0.058 | 0.167 | Cholesterol synthesis inhibitor | 0.167 0.037 CID_169730 | CID_169730 | |
| 0.098 | 0.028 | 0.13 | GABA aminotransferase inhibitor | 0.13 0.013 CID_169730 | CID_169730 | |
| 0.076 | 0.007 | 0.088 | Dopamine D5 agonist | 0.088 0.005 CID_169730 | CID_169730 | |
| 0.128 | 0.059 | 0.151 | Sphingosine 1-phosphate receptor 4 antagonist | 0.151 0.033 CID_169730 | CID_169730 | |
| 0.076 | 0.008 | 0.13 | Fumarate hydratase inhibitor | 0.13 0.004 CID_169730 | CID_169730 | |
| 0.086 | 0.019 | 0.126 | Ornithine carbamoyltransferase inhibitor | 0.126 0.012 CID_169730 | CID_169730 | |
| 0.124 | 0.057 | 0.147 | Microtubule formation inhibitor | 0.147 0.039 CID_169730 | CID_169730 | |
| 0.195 | 0.129 | 0.211 | Neuropeptide Y2 antagonist | 0.211 0.101 CID_169730 | CID_169730 | |
| 0.075 | 0.009 | 0.082 | Pregnane X receptor antagonist | 0.082 0.006 CID_169730 | CID_169730 | |
| 0.149 | 0.083 | 0.173 | Melanin inhibitor | 0.173 0.057 CID_169730 | CID_169730 | |
| 0.112 | 0.047 | 0.138 | Sphingomyelinase inhibitor | 0.138 0.03 CID_169730 | CID_169730 | |
| 0.074 | 0.01 | 0.08 | Adenylate cyclase 1 inhibitor | 0.08 0.008 CID_169730 | CID_169730 | |
| 0.09 | 0.026 | 0.09 | Acetylcholine M5 receptor agonist | 0.074 0.04 CID_169730 | ||
| 0.097 | 0.034 | 0.107 | Na+ K+ transporting ATPase inhibitor | 0.107 0.026 CID_169730 | CID_169730 | |
| 0.068 | 0.005 | 0.089 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.089 0.003 CID_169730 | CID_169730 | |
| 0.093 | 0.031 | 0.094 | CC chemokine 5 receptor agonist | 0.094 0.03 CID_169730 | CID_169730 | |
| 0.118 | 0.056 | 0.156 | Mucolytic | 0.156 0.029 CID_169730 | CID_169730 | |
| 0.112 | 0.05 | 0.149 | Carbonic anhydrase III inhibitor | 0.149 0.029 CID_169730 | CID_169730 | |
| 0.117 | 0.056 | 0.129 | Falcipain 3 inhibitor | 0.129 0.048 CID_169730 | CID_169730 | |
| 0.097 | 0.037 | 0.102 | mTOR complex 2 inhibitor | 0.102 0.03 CID_169730 | CID_169730 | |
| 0.138 | 0.077 | 0.183 | Cell wall synthesis inhibitor | 0.183 0.038 CID_169730 | CID_169730 | |
| 0.084 | 0.025 | 0.113 | NMDA receptor glycine site agonist | 0.113 0.011 CID_169730 | CID_169730 | |
| 0.087 | 0.029 | 0.098 | MAP kinase kinase 7 inhibitor | 0.098 0.015 CID_169730 | CID_169730 | |
| 0.073 | 0.015 | 0.095 | Alpha-mannosidase inhibitor | 0.095 0.007 CID_169730 | CID_169730 | |
| 0.066 | 0.009 | 0.066 | Alpha 1d adrenoreceptor agonist | 0.066 0.009 CID_169730 | ||
| 0.072 | 0.015 | 0.093 | Dihydroorotate oxidase inhibitor | 0.093 0.006 CID_169730 | CID_169730 | |
| 0.127 | 0.071 | 0.164 | Toll-Like receptor 2 antagonist | 0.164 0.043 CID_169730 | CID_169730 | |
| 0.062 | 0.006 | 0.082 | Glutamate (mGluR8) agonist | 0.082 0.004 CID_169730 | CID_169730 | |
| 0.141 | 0.089 | 0.186 | Hexokinase inhibitor | 0.186 0.044 CID_169730 | CID_169730 | |
| 0.059 | 0.007 | 0.076 | Kainate receptor agonist | 0.076 0.004 CID_169730 | CID_169730 | |
| 0.061 | 0.011 | 0.07 | Guanylate cyclase inhibitor | 0.07 0.005 CID_169730 | CID_169730 | |
| 0.072 | 0.024 | 0.078 | Calcium channel P-type blocker | 0.078 0.017 CID_169730 | CID_169730 | |
| 0.129 | 0.083 | 0.129 | Nav1.6 sodium channel blocker | 0.125 0.088 CID_169730 | ||
| 0.072 | 0.026 | 0.072 | Corticotropin releasing factor 2 receptor antagonist | 0.067 0.034 CID_169730 | ||
| 0.077 | 0.031 | 0.12 | NMDA receptor agonist | 0.12 0.013 CID_169730 | CID_169730 | |
| 0.075 | 0.03 | 0.075 | 5 Hydroxytryptamine 3 agonist | 0.073 0.032 CID_169730 | ||
| 0.06 | 0.015 | 0.065 | Dopamine beta hydroxylase inhibitor | 0.065 0.011 CID_169730 | CID_169730 | |
| 0.113 | 0.068 | 0.126 | TRPA1 agonist | 0.126 0.052 CID_169730 | CID_169730 | |
| 0.124 | 0.079 | 0.137 | Vanilloid 1 agonist | 0.137 0.055 CID_169730 | CID_169730 | |
| 0.094 | 0.049 | 0.094 | Bromodomain-containing protein 2 inhibitor | 0.092 0.052 CID_169730 | ||
| 0.061 | 0.016 | 0.084 | Mannosidase inhibitor | 0.084 0.008 CID_169730 | CID_169730 | |
| 0.209 | 0.166 | 0.285 | Vasodilator, peripheral | 0.285 0.105 CID_169730 | CID_169730 | |
| 0.067 | 0.024 | 0.089 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.089 0.013 CID_169730 | CID_169730 | |
| 0.062 | 0.02 | 0.067 | Immunoglobulin Fc receptor antagonist | 0.067 0.014 CID_169730 | CID_169730 | |
| 0.055 | 0.013 | 0.055 | Histamine H1 receptor agonist | 0.047 0.022 CID_169730 | ||
| 0.058 | 0.016 | 0.058 | Histamine H2 receptor agonist | 0.047 0.025 CID_169730 | ||
| 0.054 | 0.014 | 0.06 | Nerve growth factor antagonist | 0.06 0.009 CID_169730 | CID_169730 | |
| 0.085 | 0.045 | 0.085 | Nicotinic alpha4beta2 receptor antagonist | 0.079 0.052 CID_169730 | ||
| 0.072 | 0.033 | 0.084 | MDM2 inhibitor | 0.084 0.016 CID_169730 | CID_169730 | |
| 0.069 | 0.031 | 0.069 | Transcription factor RelA inhibitor | 0.068 0.033 CID_169730 | ||
| 0.068 | 0.029 | 0.068 | Potassium channel intermediate-conductance Ca-activated blocker | 0.063 0.036 CID_169730 | ||
| 0.078 | 0.04 | 0.078 | Potassium channel (Tandem pore domain) blocker | 0.075 0.047 CID_169730 | ||
| 0.083 | 0.045 | 0.117 | Keratolytic | 0.117 0.023 CID_169730 | CID_169730 | |
| 0.043 | 0.005 | 0.046 | Purinergic P2Y15 antagonist | 0.046 0.004 CID_169730 | CID_169730 | |
| 0.059 | 0.021 | 0.059 | Potassium channel (Inward rectifier) activator | 0.059 0.021 CID_169730 | ||
| 0.055 | 0.018 | 0.07 | Geranyltranstransferase inhibitor | 0.07 0.008 CID_169730 | CID_169730 | |
| 0.064 | 0.028 | 0.069 | Ryanodine receptor antagonist | 0.069 0.019 CID_169730 | CID_169730 | |
| 0.076 | 0.04 | 0.112 | Sphingosine 1-phosphate receptor 4 agonist | 0.112 0.02 CID_169730 | CID_169730 | |
| 0.094 | 0.059 | 0.132 | Alcohol dehydrogenase inhibitor | 0.132 0.027 CID_169730 | CID_169730 | |
| 0.056 | 0.021 | 0.056 | Potassium channel (ATP-sensitive) activator | 0.056 0.02 CID_169730 | ||
| 0.059 | 0.024 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.071 0.014 CID_169730 | CID_169730 | |
| 0.049 | 0.015 | 0.051 | Heme oxygenase inhibitor | 0.051 0.012 CID_169730 | CID_169730 | |
| 0.057 | 0.024 | 0.058 | Squalene epoxidase inhibitor | 0.058 0.022 CID_169730 | CID_169730 | |
| 0.111 | 0.078 | 0.121 | Transcription factor STAT6 inhibitor | 0.121 0.058 CID_169730 | CID_169730 | |
| 0.043 | 0.011 | 0.05 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.05 0.009 CID_169730 | CID_169730 | |
| 0.041 | 0.009 | 0.041 | Nicotinic alpha3beta4 receptor agonist | 0.035 0.014 CID_169730 | ||
| 0.061 | 0.03 | 0.081 | Sphingosine kinase 2 inhibitor | 0.081 0.015 CID_169730 | CID_169730 | |
| 0.059 | 0.03 | 0.061 | Epithelial sodium channel blocker | 0.061 0.026 CID_169730 | CID_169730 | |
| 0.058 | 0.029 | 0.059 | Nicotinic alpha3beta2 receptor antagonist | 0.059 0.028 CID_169730 | CID_169730 | |
| 0.047 | 0.018 | 0.06 | Membrane dipeptidase inhibitor | 0.06 0.01 CID_169730 | CID_169730 | |
| 0.068 | 0.04 | 0.068 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.045 CID_169730 | ||
| 0.046 | 0.019 | 0.068 | GABA uptake inhibitor | 0.068 0.008 CID_169730 | CID_169730 | |
| 0.034 | 0.007 | 0.039 | Hedgehog signaling activator | 0.039 0.005 CID_169730 | CID_169730 | |
| 0.082 | 0.055 | 0.11 | Carbonic anhydrase VI inhibitor | 0.11 0.033 CID_169730 | CID_169730 | |
| 0.041 | 0.014 | 0.041 | Potassium channel small-conductance Ca-activated activator | 0.031 0.022 CID_169730 | ||
| 0.086 | 0.06 | 0.109 | Ornithine decarboxylase inhibitor | 0.109 0.035 CID_169730 | CID_169730 | |
| 0.039 | 0.012 | 0.056 | Uridine phosphorylase inhibitor | 0.056 0.007 CID_169730 | CID_169730 | |
| 0.05 | 0.024 | 0.054 | Oxytocin agonist | 0.054 0.021 CID_169730 | CID_169730 | |
| 0.033 | 0.007 | 0.037 | Vanilloid 2 agonist | 0.037 0.005 CID_169730 | CID_169730 | |
| 0.033 | 0.008 | 0.05 | Glutamate (mGluR1a) agonist | 0.05 0.005 CID_169730 | CID_169730 | |
| 0.16 | 0.135 | 0.2 | Cyclic AMP phosphodiesterase inhibitor | 0.2 0.093 CID_169730 | CID_169730 | |
| 0.06 | 0.035 | 0.078 | Carbonic anhydrase VB inhibitor | 0.078 0.023 CID_169730 | CID_169730 | |
| 0.118 | 0.094 | 0.167 | Protein kinase stimulant | 0.167 0.057 CID_169730 | CID_169730 | |
| 0.052 | 0.028 | 0.066 | Adenosine deaminase inhibitor | 0.066 0.016 CID_169730 | CID_169730 | |
| 0.037 | 0.013 | 0.047 | Glutamate (mGluR3) agonist | 0.047 0.005 CID_169730 | CID_169730 | |
| 0.028 | 0.005 | 0.033 | Carbonic anhydrase VIII inhibitor | 0.033 0.004 CID_169730 | CID_169730 | |
| 0.028 | 0.005 | 0.033 | Carbonic anhydrase X inhibitor | 0.033 0.004 CID_169730 | CID_169730 | |
| 0.041 | 0.018 | 0.061 | Phosphoglycerate kinase inhibitor | 0.061 0.011 CID_169730 | CID_169730 | |
| 0.03 | 0.008 | 0.03 | Complement factor 1s inhibitor | 0.028 0.01 CID_169730 | ||
| 0.034 | 0.012 | 0.034 | Nicotinic alpha4beta2 receptor agonist | 0.03 0.017 CID_169730 | ||
| 0.041 | 0.019 | 0.044 | Vanilloid 3 antagonist | 0.044 0.015 CID_169730 | CID_169730 | |
| 0.065 | 0.043 | 0.079 | Interferon inducer | 0.079 0.025 CID_169730 | CID_169730 | |
| 0.046 | 0.025 | 0.067 | Glutamate (mGluR4) antagonist | 0.067 0.011 CID_169730 | CID_169730 | |
| 0.032 | 0.011 | 0.041 | Nicotinic acid receptor 2 antagonist | 0.041 0.005 CID_169730 | CID_169730 | |
| 0.077 | 0.057 | 0.095 | Interferon agonist | 0.095 0.034 CID_169730 | CID_169730 | |
| 0.041 | 0.021 | 0.058 | Arginase inhibitor | 0.058 0.011 CID_169730 | CID_169730 | |
| 0.041 | 0.021 | 0.041 | Potassium channel Kv1.1 blocker | 0.036 0.03 CID_169730 | ||
| 0.091 | 0.071 | 0.105 | Bile acid receptor antagonist | 0.105 0.039 CID_169730 | CID_169730 | |
| 0.04 | 0.021 | 0.062 | Glutamate (mGluR3) antagonist | 0.062 0.008 CID_169730 | CID_169730 | |
| 0.044 | 0.024 | 0.055 | Thymidine kinase inhibitor | 0.055 0.016 CID_169730 | CID_169730 | |
| 0.032 | 0.013 | 0.04 | Estrogen-related receptor gamma antagonist | 0.04 0.005 CID_169730 | CID_169730 | |
| 0.059 | 0.041 | 0.075 | Carbonic anhydrase stimulant | 0.075 0.028 CID_169730 | CID_169730 | |
| 0.049 | 0.031 | 0.052 | Cytokine production stimulant | 0.052 0.025 CID_169730 | CID_169730 | |
| 0.064 | 0.046 | 0.065 | Aryl hydrocarbon receptor antagonist | 0.065 0.045 CID_169730 | CID_169730 | |
| 0.023 | 0.005 | 0.027 | Telomerase stimulant | 0.027 0.004 CID_169730 | CID_169730 | |
| 0.111 | 0.094 | 0.125 | DNA repair enzyme inhibitor | 0.125 0.063 CID_169730 | CID_169730 | |
| 0.029 | 0.012 | 0.036 | Lysophosphatidic acid receptor 1 agonist | 0.036 0.007 CID_169730 | CID_169730 | |
| 0.079 | 0.063 | 0.097 | Glutathione S-transferase inhibitor | 0.097 0.04 CID_169730 | CID_169730 | |
| 0.029 | 0.013 | 0.034 | Thymidine phosphorylase inhibitor | 0.034 0.009 CID_169730 | CID_169730 | |
| 0.128 | 0.112 | 0.143 | MAP kinase 3 inhibitor | 0.143 0.08 CID_169730 | CID_169730 | |
| 0.037 | 0.022 | 0.046 | Tryptophan 5 hydroxylase inhibitor | 0.046 0.008 CID_169730 | CID_169730 | |
| 0.044 | 0.03 | 0.056 | AICAR transformylase inhibitor | 0.056 0.016 CID_169730 | CID_169730 | |
| 0.04 | 0.026 | 0.049 | Dihydropteroate synthase inhibitor | 0.049 0.017 CID_169730 | CID_169730 | |
| 0.021 | 0.007 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 CID_169730 | CID_169730 | |
| 0.058 | 0.044 | 0.074 | Androgen agonist | 0.074 0.028 CID_169730 | CID_169730 | |
| 0.031 | 0.017 | 0.031 | MAP3K8 inhibitor | 0.029 0.019 CID_169730 | ||
| 0.047 | 0.033 | 0.048 | CC chemokine 4 receptor antagonist | 0.048 0.031 CID_169730 | CID_169730 | |
| 0.028 | 0.014 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 CID_169730 | CID_169730 | |
| 0.072 | 0.059 | 0.099 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.099 0.038 CID_169730 | CID_169730 | |
| 0.019 | 0.006 | 0.026 | Thromboxane A2 agonist | 0.026 0.004 CID_169730 | CID_169730 | |
| 0.017 | 0.005 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.019 0.004 CID_169730 | CID_169730 | |
| 0.023 | 0.01 | 0.026 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.026 0.006 CID_169730 | CID_169730 | |
| 0.047 | 0.034 | 0.049 | Aldosterone antagonist | 0.049 0.031 CID_169730 | CID_169730 | |
| 0.021 | 0.01 | 0.021 | Cyclin T1 inhibitor | 0.021 0.01 CID_169730 | ||
| 0.091 | 0.08 | 0.128 | Expectorant | 0.128 0.045 CID_169730 | CID_169730 | |
| 0.04 | 0.028 | 0.045 | CF transmembrane conductance regulator antagonist | 0.045 0.014 CID_169730 | CID_169730 | |
| 0.024 | 0.013 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 CID_169730 | CID_169730 | |
| 0.039 | 0.028 | 0.039 | 5 Hydroxytryptamine 2B agonist | |||
| 0.077 | 0.066 | 0.077 | Calcium antagonist | 0.077 0.066 CID_169730 | ||
| 0.017 | 0.006 | 0.024 | Lysophosphatidic acid receptor 3 agonist | 0.024 0.004 CID_169730 | CID_169730 | |
| 0.043 | 0.032 | 0.059 | Glutamate (mGluR group III) antagonist | 0.059 0.014 CID_169730 | CID_169730 | |
| 0.026 | 0.016 | 0.026 | Acid ceramidase inhibitor | 0.024 0.023 CID_169730 | ||
| 0.089 | 0.079 | 0.111 | Urease inhibitor | 0.111 0.055 CID_169730 | CID_169730 | |
| 0.018 | 0.008 | 0.02 | Purinergic P2Y1 agonist | 0.02 0.006 CID_169730 | CID_169730 | |
| 0.028 | 0.018 | 0.04 | Lysine carboxypeptidase inhibitor | 0.04 0.01 CID_169730 | CID_169730 | |
| 0.019 | 0.01 | 0.019 | Alpha 2a adrenoreceptor agonist | 0.019 0.01 CID_169730 | ||
| 0.064 | 0.054 | 0.078 | Carbonic anhydrase VA inhibitor | 0.078 0.039 CID_169730 | CID_169730 | |
| 0.015 | 0.006 | 0.023 | Glutamate (mGluR6) agonist | 0.023 0.004 CID_169730 | CID_169730 | |
| 0.033 | 0.024 | 0.039 | Protein kinase (CK2) beta inhibitor | 0.039 0.014 CID_169730 | CID_169730 | |
| 0.035 | 0.026 | 0.044 | Ceramide glucosyltransferase inhibitor | 0.044 0.012 CID_169730 | CID_169730 | |
| 0.015 | 0.006 | 0.016 | Carbonic anhydrase XI inhibitor | 0.016 0.006 CID_169730 | CID_169730 | |
| 0.021 | 0.013 | 0.021 | Imidazoline I1 receptor antagonist | |||
| 0.023 | 0.015 | 0.031 | Prostaglandin F2 alpha agonist | 0.031 0.008 CID_169730 | CID_169730 | |
| 0.031 | 0.023 | 0.043 | ATP citrate lysase inhibitor | 0.043 0.011 CID_169730 | CID_169730 | |
| 0.085 | 0.078 | 0.115 | MAP kinase kinase 1 inhibitor | 0.115 0.039 CID_169730 | CID_169730 | |
| 0.019 | 0.012 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.007 CID_169730 | CID_169730 | |
| 0.021 | 0.014 | 0.026 | Retinoid X beta receptor antagonist | 0.026 0.006 CID_169730 | CID_169730 | |
| 0.035 | 0.028 | 0.046 | Integrin alpha2 antagonist | 0.046 0.014 CID_169730 | CID_169730 | |
| 0.034 | 0.027 | 0.034 | Adenosine uptake inhibitor | 0.033 0.029 CID_169730 | ||
| 0.03 | 0.023 | 0.03 | Epoxide hydrolase 1 inhibitor | 0.029 0.025 CID_169730 | ||
| 0.054 | 0.047 | 0.061 | Leukotriene C antagonist | 0.061 0.027 CID_169730 | CID_169730 | |
| 0.026 | 0.019 | 0.034 | Integrin alpha2beta1 antagonist | 0.034 0.009 CID_169730 | CID_169730 | |
| 0.067 | 0.061 | 0.098 | Carbonic anhydrase XIII inhibitor | 0.098 0.039 CID_169730 | CID_169730 | |
| 0.018 | 0.011 | 0.026 | Nicotinic acid receptor 1 antagonist | 0.026 0.005 CID_169730 | CID_169730 | |
| 0.024 | 0.018 | 0.031 | Glutamate (mGluR1) agonist | 0.031 0.009 CID_169730 | CID_169730 | |
| 0.021 | 0.015 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.026 0.006 CID_169730 | CID_169730 | |
| 0.028 | 0.022 | 0.028 | 5 Hydroxytryptamine 6 agonist | |||
| 0.041 | 0.037 | 0.048 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.027 CID_169730 | CID_169730 | |
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | 0.009 0.004 CID_169730 | ||
| 0.041 | 0.037 | 0.058 | Dihydroorotase inhibitor | 0.058 0.018 CID_169730 | CID_169730 | |
| 0.016 | 0.012 | 0.016 | Nicotinic alpha4 receptor agonist | |||
| 0.042 | 0.039 | 0.042 | Purinergic P2X4 antagonist | 0.042 0.039 CID_169730 | ||
| 0.035 | 0.031 | 0.035 | Delayed rectifier potassium channel blocker | |||
| 0.02 | 0.017 | 0.02 | Factor XIII inhibitor | |||
| 0.025 | 0.022 | 0.035 | Sodium/glucose cotransporter 2 inhibitor | 0.035 0.01 CID_169730 | CID_169730 | |
| 0.028 | 0.025 | 0.038 | Lysophosphatidic acid 2 receptor antagonist | 0.038 0.014 CID_169730 | CID_169730 | |
| 0.09 | 0.087 | 0.108 | Beta glucuronidase inhibitor | 0.108 0.059 CID_169730 | CID_169730 | |
| 0.049 | 0.047 | 0.059 | Heparanase inhibitor | 0.059 0.025 CID_169730 | CID_169730 | |
| 0.045 | 0.043 | 0.056 | Topoisomerase II beta inhibitor | 0.056 0.026 CID_169730 | CID_169730 | |
| 0.045 | 0.043 | 0.05 | Bombesin 2 receptor antagonist | 0.05 0.033 CID_169730 | CID_169730 | |
| 0.035 | 0.033 | 0.047 | Retinoid X receptor antagonist | 0.047 0.015 CID_169730 | CID_169730 | |
| 0.033 | 0.032 | 0.038 | Diamine oxidase inhibitor | 0.038 0.026 CID_169730 | CID_169730 | |
| 0.026 | 0.025 | 0.026 | Glucosylceramidase stimulant | |||
| 0.031 | 0.03 | 0.041 | Retinoid X alpha receptor antagonist | 0.041 0.013 CID_169730 | CID_169730 | |
| 0.095 | 0.094 | 0.125 | Alkylator | 0.125 0.063 CID_169730 | CID_169730 | |
| 0.02 | 0.019 | 0.02 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.03 | 0.03 | 0.043 | Free fatty acid receptor 1 antagonist | 0.043 0.013 CID_169730 | CID_169730 | |
| 0.05 | 0.049 | 0.07 | Glucosylceramidase inhibitor | 0.07 0.022 CID_169730 | CID_169730 | |
| 0.057 | 0.057 | 0.074 | Carbonic anhydrase V inhibitor | 0.074 0.039 CID_169730 | CID_169730 | |
| 0.021 | 0.021 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.015 CID_169730 | CID_169730 | |
| 0.009 | 0.01 | 0.014 | Thromboxane agonist | 0.014 0.005 CID_169730 | CID_169730 | |
| 0.009 | 0.01 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 CID_169730 | CID_169730 | |
| 0.136 | 0.137 | 0.162 | I kappa B kinase epsilon inhibitor | 0.162 0.107 CID_169730 | CID_169730 | |
| 0.091 | 0.093 | 0.134 | Adenylate cyclase inhibitor | 0.134 0.056 CID_169730 | CID_169730 | |
| 0.03 | 0.031 | 0.051 | Retinoid X alpha receptor agonist | 0.051 0.014 CID_169730 | CID_169730 | |
| 0.075 | 0.077 | 0.085 | Myeloperoxidase inhibitor | 0.085 0.058 CID_169730 | CID_169730 | |
| 0.034 | 0.036 | 0.044 | Toll-Like receptor 2 agonist | 0.044 0.026 CID_169730 | CID_169730 | |
| 0.028 | 0.03 | 0.034 | Methionyl aminopeptidase 1 inhibitor | 0.034 0.019 CID_169730 | CID_169730 | |
| 0.098 | 0.101 | 0.122 | Interleukin 8 antagonist | 0.122 0.059 CID_169730 | CID_169730 | |
| 0.053 | 0.055 | 0.068 | Sphingosine kinase inhibitor | 0.068 0.027 CID_169730 | CID_169730 | |
| 0.038 | 0.041 | 0.046 | GABA B receptor antagonist | 0.046 0.025 CID_169730 | CID_169730 | |
| 0.023 | 0.026 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 CID_169730 | CID_169730 | |
| 0.141 | 0.145 | 0.189 | Insulin sensitizer | 0.189 0.085 CID_169730 | CID_169730 | |
| 0.051 | 0.055 | 0.06 | Botulinum neurotoxin type A inhibitor | 0.06 0.037 CID_169730 | CID_169730 | |
| 0.052 | 0.057 | 0.056 | Cyclin D1 inhibitor | 0.056 0.049 CID_169730 | CID_169730 | |
| 0.027 | 0.031 | 0.031 | Calcitonin receptor agonist | 0.031 0.026 CID_169730 | CID_169730 | |
| 0.005 | 0.01 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.005 CID_169730 | CID_169730 | |
| 0.034 | 0.039 | 0.048 | AMPA 4 receptor antagonist | 0.048 0.017 CID_169730 | CID_169730 | |
| 0.009 | 0.015 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 CID_169730 | CID_169730 | |
| 0.029 | 0.036 | 0.036 | Glutamate (mGluR4) agonist | 0.036 0.02 CID_169730 | CID_169730 | |
| 0.012 | 0.02 | 0.016 | Aminopeptidase A inhibitor | 0.016 0.014 CID_169730 | CID_169730 | |
| 0.06 | 0.068 | 0.073 | Cathepsin G inhibitor | 0.073 0.05 CID_169730 | CID_169730 | |
| 0.042 | 0.051 | 0.045 | HCV NS3/NS4A protease inhibitor | 0.045 0.042 CID_169730 | CID_169730 | |
| 0.035 | 0.043 | 0.04 | Leukotriene C4 antagonist | 0.04 0.024 CID_169730 | CID_169730 | |
| 0.028 | 0.037 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.022 CID_169730 | CID_169730 | |
| 0.019 | 0.028 | 0.036 | Kynurenine 3 monooxygenase inhibitor | 0.036 0.011 CID_169730 | CID_169730 | |
| 0.072 | 0.081 | 0.076 | Caspase 7 inhibitor | 0.076 0.072 CID_169730 | CID_169730 | |
| 0.023 | 0.033 | 0.027 | Peptide deformylase inhibitor | 0.027 0.026 CID_169730 | CID_169730 | |
| 0.084 | 0.094 | 0.094 | Phosphodiesterase 6D inhibitor | 0.094 0.066 CID_169730 | CID_169730 | |
| 0.02 | 0.03 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.021 CID_169730 | CID_169730 | |
| 0.035 | 0.045 | 0.05 | Glutamate (mGluR group III) agonist | 0.05 0.023 CID_169730 | CID_169730 | |
| 0.136 | 0.147 | 0.146 | Aryl hydrocarbon receptor agonist | 0.146 0.139 CID_169730 | CID_169730 | |
| 0.015 | 0.026 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.013 CID_169730 | CID_169730 | |
| 0.011 | 0.023 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.014 CID_169730 | CID_169730 | |
| 0.036 | 0.049 | 0.052 | Thymidylate synthase inhibitor | 0.052 0.025 CID_169730 | CID_169730 | |
| 0.024 | 0.038 | 0.048 | Kainate receptor 2 antagonist | 0.048 0.017 CID_169730 | CID_169730 | |
| 0.048 | 0.062 | 0.059 | Sphingosine 1-phosphate receptor 3 antagonist | 0.059 0.04 CID_169730 | CID_169730 | |
| 0.034 | 0.048 | 0.045 | Sphingosine kinase 1 inhibitor | 0.045 0.023 CID_169730 | CID_169730 | |
| 0.128 | 0.143 | 0.164 | MAP kinase kinase 2 inhibitor | 0.164 0.109 CID_169730 | CID_169730 | |
| 0.023 | 0.038 | 0.05 | Retinoid X receptor agonist | 0.05 0.018 CID_169730 | CID_169730 | |
| 0.015 | 0.031 | 0.029 | Prostaglandin H2 antagonist | 0.029 0.014 CID_169730 | CID_169730 | |
| 0.02 | 0.036 | 0.027 | Thyroid hormone agonist | 0.027 0.016 CID_169730 | CID_169730 | |
| 0.042 | 0.06 | 0.051 | CD45 antagonist | 0.051 0.033 CID_169730 | CID_169730 | |
| 0.114 | 0.133 | 0.124 | Thiol protease inhibitor | 0.124 0.109 CID_169730 | CID_169730 | |
| 0.045 | 0.064 | 0.064 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.064 0.036 CID_169730 | CID_169730 | |
| 0.033 | 0.052 | 0.042 | Angiotensin AT1 receptor antagonist | 0.042 0.03 CID_169730 | CID_169730 | |
| 0.055 | 0.074 | 0.068 | Beta 3 adrenoreceptor antagonist | 0.068 0.036 CID_169730 | CID_169730 | |
| 0.103 | 0.123 | 0.127 | Cytidine deaminase inhibitor | 0.127 0.094 CID_169730 | CID_169730 | |
| 0.154 | 0.174 | 0.162 | Calpain inhibitor | 0.162 0.161 CID_169730 | CID_169730 | |
| 0.012 | 0.034 | 0.022 | Prostaglandin EP2 agonist | 0.022 0.016 CID_169730 | CID_169730 | |
| 0.046 | 0.069 | 0.064 | NMDA 2C receptor antagonist | 0.064 0.039 CID_169730 | CID_169730 | |
| 0.014 | 0.037 | 0.023 | NMDA receptor glycine site antagonist | 0.023 0.018 CID_169730 | CID_169730 | |
| 0.018 | 0.041 | 0.03 | Liver X receptor beta antagonist | 0.03 0.019 CID_169730 | CID_169730 | |
| 0.008 | 0.031 | 0.015 | G-protein-coupled receptor 120 agonist | 0.015 0.014 CID_169730 | CID_169730 | |
| 0.032 | 0.056 | 0.043 | Antimetabolite | 0.043 0.037 CID_169730 | CID_169730 | |
| 0.136 | 0.16 | 0.159 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.159 0.132 CID_169730 | CID_169730 | |
| 0.016 | 0.041 | 0.024 | CXC chemokine 2 receptor antagonist | 0.024 0.021 CID_169730 | CID_169730 | |
| 0.055 | 0.079 | 0.063 | Beta 2 adrenoreceptor agonist | 0.063 0.037 CID_169730 | CID_169730 | |
| 0.121 | 0.146 | 0.158 | Psychostimulant | 0.158 0.109 CID_169730 | CID_169730 | |
| 0.019 | 0.044 | 0.025 | LFA antagonist | 0.025 0.024 CID_169730 | CID_169730 | |
| 0.023 | 0.049 | 0.042 | Nicotinic acid receptor agonist | 0.042 0.019 CID_169730 | CID_169730 | |
| 0.03 | 0.057 | 0.049 | NMDA receptor subunit 3B antagonist | 0.049 0.026 CID_169730 | CID_169730 | |
| 0.047 | 0.076 | 0.056 | Heat shock protein 90 beta antagonist | 0.056 0.046 CID_169730 | CID_169730 | |
| 0.018 | 0.048 | 0.029 | Prostaglandin agonist | 0.029 0.024 CID_169730 | CID_169730 | |
| 0.06 | 0.09 | 0.079 | Macrophage migration inhibitory factor inhibitor | 0.079 0.052 CID_169730 | CID_169730 | |
| 0.031 | 0.062 | 0.046 | Ribonucleoside-diphosphate reductase inhibitor | 0.046 0.043 CID_169730 | CID_169730 | |
| 0.022 | 0.053 | 0.038 | Farnesoid X receptor agonist | 0.038 0.027 CID_169730 | CID_169730 | |
| 0.031 | 0.062 | 0.047 | Ribonucleotide reductase inhibitor | 0.047 0.044 CID_169730 | CID_169730 | |
| 0.065 | 0.096 | 0.104 | Potassium channel (Ca-activated) activator | 0.104 0.052 CID_169730 | CID_169730 | |
| 0.136 | 0.168 | 0.201 | Immunostimulant | 0.201 0.119 CID_169730 | CID_169730 | |
| 0.062 | 0.094 | 0.073 | Estrogen receptor alpha antagonist | 0.073 0.062 CID_169730 | CID_169730 | |
| 0.007 | 0.041 | 0.018 | Kainate receptor 1 antagonist | 0.018 0.017 CID_169730 | CID_169730 | |
| 0.052 | 0.085 | 0.064 | Protein kinase C beta inhibitor | 0.064 0.061 CID_169730 | CID_169730 | |
| 0.081 | 0.115 | 0.097 | Protein kinase C gamma inhibitor | 0.097 0.083 CID_169730 | CID_169730 | |
| 0.024 | 0.059 | 0.038 | Urate transporter 1 inhibitor | 0.038 0.028 CID_169730 | CID_169730 | |
| 0.176 | 0.211 | 0.242 | Antithrombotic | 0.242 0.132 CID_169730 | CID_169730 | |
| 0.021 | 0.059 | 0.038 | NMDA receptor subunit 3A antagonist | 0.038 0.026 CID_169730 | CID_169730 | |
| 0.02 | 0.061 | 0.041 | Kainate receptor antagonist | 0.041 0.028 CID_169730 | CID_169730 | |
| 0.073 | 0.116 | 0.093 | Xanthine oxidase inhibitor | 0.093 0.066 CID_169730 | CID_169730 | |
| 0.039 | 0.084 | 0.052 | Thromboxane synthase inhibitor | 0.052 0.042 CID_169730 | CID_169730 | |
| 0.09 | 0.135 | 0.109 | Alkaline phosphatase inhibitor | 0.109 0.101 CID_169730 | CID_169730 | |
| 0.082 | 0.127 | 0.111 | Caspase 3 inhibitor | 0.111 0.074 CID_169730 | CID_169730 | |
| 0.088 | 0.135 | 0.108 | NADPH oxidase inhibitor | 0.108 0.1 CID_169730 | CID_169730 | |
| 0.071 | 0.12 | 0.096 | Interleukin 1 beta converting enzyme inhibitor | 0.096 0.063 CID_169730 | CID_169730 | |
| 0.11 | 0.161 | 0.146 | Pyruvate kinase inhibitor | 0.146 0.118 CID_169730 | CID_169730 | |
| 0.11 | 0.162 | 0.152 | DNA methyltransferase I inhibitor | 0.152 0.101 CID_169730 | CID_169730 | |
| 0.033 | 0.085 | 0.055 | Beta 1 adrenoreceptor antagonist | 0.055 0.04 CID_169730 | CID_169730 | |
| 0.029 | 0.083 | 0.048 | Beta 2 adrenoreceptor antagonist | 0.048 0.04 CID_169730 | CID_169730 | |
| 0.024 | 0.081 | 0.043 | Thromboxane A2 antagonist | 0.043 0.042 CID_169730 | CID_169730 | |
| 0.027 | 0.086 | 0.05 | Xanthine dehydrogenase inhibitor | 0.05 0.046 CID_169730 | CID_169730 | |
| 0.137 | 0.197 | 0.163 | DNA damaging | 0.163 0.154 CID_169730 | CID_169730 | |
| 0.027 | 0.087 | 0.047 | Thromboxane antagonist | 0.047 0.045 CID_169730 | CID_169730 | |
| 0.072 | 0.133 | 0.1 | AMP-activated protein kinase stimulant | 0.1 0.071 CID_169730 | CID_169730 | |
| 0.053 | 0.117 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | 0.066 0.063 CID_169730 | CID_169730 | |
| 0.04 | 0.108 | 0.062 | Beta adrenoreceptor antagonist | 0.062 0.051 CID_169730 | CID_169730 | |
| 0.051 | 0.126 | 0.092 | Monophenol monooxygenase inhibitor | 0.092 0.082 CID_169730 | CID_169730 | |
| 0.145 | 0.221 | 0.177 | Transcription factor STAT3 inhibitor | 0.177 0.169 CID_169730 | CID_169730 | |
| 0.105 | 0.182 | 0.152 | DNA methylase inhibitor | 0.152 0.116 CID_169730 | CID_169730 | |
| 0.141 | 0.222 | 0.186 | 12-Lipoxygenase inhibitor | 0.186 0.167 CID_169730 | CID_169730 | |
| 0.087 | 0.176 | 0.126 | Phospholipase A2 inhibitor | 0.126 0.108 CID_169730 | CID_169730 | |
| 0.143 | 0.235 | 0.206 | Transcription factor NF kappa B inhibitor | 0.206 0.163 CID_169730 | CID_169730 | |
| 0.106 | 0.199 | 0.143 | Non-steroidal antiinflammatory agent | 0.143 0.125 CID_169730 | CID_169730 | |
| 0 | 0.378 | 0.009 | Mannitol 2-dehydrogenase inhibitor | 0.009 0.005 CID_169730 | CID_169730 | |
| 0.04 | 0.969 | 0.23 | Peptidyltransferase inhibitor | 0.23 0.067 CID_169730 | CID_169730 | |
| 0.01 | 0.94 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.041 CID_169730 | CID_169730 | |
| 0.006 | 0.963 | 0.039 | Glutamate (mGluR8) antagonist | 0.039 0.019 CID_169730 | CID_169730 | |
| 0.007 | 0.988 | 0.054 | DNA helicase inhibitor | 0.054 0.039 CID_169730 | CID_169730 | |
| 0.014 | 0.996 | 0.241 | Interleukin 2 agonist | 0.241 0.129 CID_169730 | CID_169730 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |